Nestlé Acquires Peanut Allergy Treatment Maker, Aimmune Therapeutics
Nestlé has announced that it has completed the acquisition of Aimmune Therapeutics, Inc., the maker of peanut allergy treatment, Palforzia.
Aimmune Therapeutics will be a part of Nestlé Health Science (NHSc) as a stand-alone business unit and continue to operate from Brisbane, California.
In August of this year, Nestlé offered $2 billion (€1.7 billion) to gain full ownership of the California-based biopharmaceutical company.
ESM
Related news
In Germany, the price of cigarettes could increase by up to 2 euros, and VAT on medicines would be reduced
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >
Nestlé is working on selling its water division
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Related news
How Coca-Cola plans to build more billion-dollar brands
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >
Tesco sets out store expansion plans in 2026 including five former Amazon Fresh sites
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >
Brits Embrace At‑Home Celebrations While Germans Cut Back on Valentine’s Day Spending
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >
